Rising healthcare prices are forcing patients to trade care for survival
Bill McAdams had a stroke while uninsured, after a health plan priced at $3,600 a month put coverage out of reach for him and his wife. The hospital bill that followed landed at $93,000. Janet Marx sold the home where she grew up. Sheila Robinson pays a $659 monthly premium on a credit card and still tries to avoid visiting the doctor because her deductible is $10,000. The financial math is brutal, and it is reshaping medical decisions long before a clinician ever orders a test or writes a prescription.
The pressure is spreading across income levels and insurance types. Americans are skipping coverage, rationing medications, postponing procedures, and negotiating self-pay discounts because premiums, copayments, deductibles, and debt collection are all climbing at once. In practical terms, the cost of being sick has become a second diagnosis. For many households, the treatment plan now starts with calculating whether care can be afforded at all.
Premiums, deductibles and bills are driving patients out of routine care
Marx lives with lupus and fibromyalgia, two chronic conditions that make steady care a necessity rather than a luxury. Even with Medicare and coverage through her husband’s employer, her out-of-pocket costs remained high enough to push the family into a devastating choice: keep the house or keep paying for medical care. Selling the home where she grew up was not a symbolic gesture. It was a financial release valve for a system that kept generating copays, therapy charges and other recurring expenses.
Robinson’s experience shows how high-deductible coverage changes behavior in real time. When patients know they may owe thousands before insurance meaningfully helps, they delay care, negotiate prices, or simply stay away. She has arthritis, a pinched nerve in her neck, and high blood pressure, conditions that usually demand continuity. Instead, she is trying to keep up with premiums by putting them on a credit card, a move that converts healthcare into revolving consumer debt. The result is a patient who feels she cannot safely enter the system she technically belongs to.
Damien Waikoloa, a 35-year-old small-business owner in Honolulu, faced a different version of the same trap. His ACA premiums rose to more than $400 a month from about $240 a month the year before. Keeping coverage meant trimming his own pay and cutting back on dining, travel and plans for a home or family. When premiums rise this fast, insurance ceases to feel like protection and starts functioning like a competing monthly bill.
The price problem begins with what the system charges
U.S. health spending reached nearly $5.3 trillion in 2024, up from $3 trillion a decade earlier. Per person, annual spending topped the equivalent of more than $15,400. The increase is not just a reflection of a sicker population. Prices themselves are high, and utilization adds another layer. Hospitals, clinicians, drugmakers and other parts of the system all bill more, and more services are delivered through a structure that rewards volume over value.
Fee-for-service payment sits at the center of that machinery. More than half of U.S. healthcare payments were still based on that model in 2022, meaning hospitals and physicians earn more when they bill more. A knee replacement is a useful example: compared with other wealthy countries, the U.S. performs about a third as many inpatient knee replacements, yet the cost per surgery is higher than in most of those nations. Less care does not automatically mean lower spending when each unit of care carries a premium price.
Administrative complexity adds another drag. Multiple billing systems, insurers, networks and reimbursement rules create layers of overhead, and the cost of paperwork and billing can reach hundreds of billions of dollars. Consumers see the burden as surprise statements, narrow networks, prepayments, and deductibles that arrive before treatment even starts. Insurers try to contain costs by limiting reimbursement, but patients often absorb the gap. The administrative design itself becomes part of the medical bill.
Market power and weak restraints keep prices elevated
Hospital consolidation has given large systems more leverage to charge higher rates. New technologies and therapies can also come with very high price tags, including drugs like GLP-1s used for weight loss and diabetes. Inflation has pushed up the cost of supplies and devices, and tariffs add still more pressure to items ranging from latex gloves to equipment. Uninsured people leave fewer pools of money to spread the risk, so each remaining insured patient can end up carrying more of the burden.
Christopher Whaley’s assessment fits the pattern: “It’s really everything all together at once.” A fragmented financing system allows hospitals, doctors, insurers and drug companies to set prices in different ways, and no single actor is responsible for bringing the total down. Unlike countries that centrally set prices or tightly regulate national spending, the U.S. leaves more room for local negotiation and more room for pricing power. Steven Ullmann described the result plainly: the same city can produce wildly different prices for the same procedure with no obvious difference in quality. In that setting, cost is not a marker of value. It is often just a marker of market strength.
One line captures the bedside consequence: expensive care keeps patients away from care.
Medical debt is changing behavior long before the next emergency
Carmilla Collins in Omaha had wages garnished after a health system pursued unpaid bills. She was insured at times and uninsured at others, and she never assumed that routine testing and preventive procedures would become a financial threat until the debts started landing. When a court allowed a collector to take money from her paycheck, she nearly missed rent. She eventually qualified for financial assistance, but only after delaying thyroid surgery for four months while a goiter made it hard to eat. Her words are stark because they describe a common medical tradeoff: she associated treatment with debt she could not afford.
Lynn Ludaway, diagnosed with multiple sclerosis, considered divorcing her husband simply to qualify for aid. Even with coverage through his job, the bills kept coming. The emotional and legal stress surrounding insurance eligibility, household income and chronic disease can be as destabilizing as the illness itself. Patients are not only managing symptoms. They are managing invoices, collections, and the risk that treatment will damage their finances more than the disease damages their body.
Federal policy choices are widening the gap between need and access
The latest cost pressures are not happening in a vacuum. Congress declined to extend pandemic-era subsidies for Affordable Care Act plans, and federal cuts were used to offset tax cuts and immigration enforcement. At the same time, higher-deductible plans have gained more traction, shifting more of the cost exposure onto people when they actually need care. Employers are also passing expenses to workers, while some clinicians now demand payment up front.
There has been one partial relief point: prescription drug prices recorded their biggest drop in decades this year after pressure from both the Biden and Trump administrations. Even so, the larger pattern remains unchanged. Premiums are rising, deductibles are rising, and debt collection is still powerful enough to push patients to delay surgery, ration care or abandon insurance entirely. Public polling reflects that strain. Healthcare costs remain among the public’s top worries, and most Democrats and Republicans alike say the system needs either major changes or a complete overhaul.
The harder question is not whether patients are hurting. They are. The harder question is what policy makers are willing to reduce: prices, profits, administrative waste, or access to care.